Department of Medicine

March 18, 2024

VUMC’s Sunil Kripalani joins AHRQ Advisory Council

The Agency for Healthcare Research and Quality Council helps guide national priorities for health services research that promotes improvements in the quality, safety and efficiency of clinical practice, and which provides equitable access to health care.

By Bill Snyder
March 15, 2024

Emerging Infections Program extends, expands disease surveillance research with new grant from the CDC

The Tennessee Emerging Infections Program has been awarded a new five-year grant from the Centers for Disease Control and Prevention to continue infectious disease surveillance research that has been conducted since 1999, and has expanded to include COVID, Mpox and HPV surveillance into oropharyngeal cancers.

By VUMC News and Communications
3d rendering white blood cells with red blood cells
March 14, 2024

Immune cell profiles may guide flu vaccine timing in pediatric stem cell transplant patients

A new study led by Vanderbilt University Medical Center researchers has identified key immune cell populations that predict how well pediatric hematopoietic stem cell transplant (HCT) recipients will respond to the influenza vaccine.

By Paul Govern
March 14, 2024

Pain medication. Cosmetics. Cleaning supplies. Tennessee Poison Center’s message: lock them away.

TPC’s help hotline —1-800-222-1222 — is staffed by nurses, pharmacists, physicians and board-certified medical toxicologists who are specially trained to assist callers.

By Jessica Pasley
March 11, 2024

School of Medicine in top 10 in NIH funding: survey

Vanderbilt University School of Medicine, which received $527.7 million in direct and indirect NIH grant support in FY23, has been among the top 10 U.S. medical schools in NIH funding for six of the last 10 years.

By Bill Snyder
March 8, 2024

Scalp cooling allows woman to keep hair during chemotherapy

The Food and Drug Administration first granted marketing approval for the DigniCap system for patients with breast cancer in 2015, then in 2017 the FDA expanded the authorization, making it the first cooling cap cleared for use in cancer patients with solid tumors, such as breast cancer, ovarian cancer and colorectal cancer.

By Tom Wilemon
March 8, 2024

Douglas Ruderfer to direct new Center for Digital Genomic Medicine

Douglas Ruderfer, PhD, whose research at Vanderbilt University Medical Center explores the intersection of genomics, biomedical informatics and psychiatry, has been named director of a newly established Center for Digital Genomic Medicine.
By Bill Snyder
March 7, 2024

Study details metabolism of biomarkers for oxidative stress

Factors other than oxidative stress can modify the levels of biomarkers called isoprostanes that are commonly used in both experimental and clinical research, suggesting that additional standards need to be developed.
By Leigh MacMillan
March 7, 2024

Blood mutations increase risk for acute kidney injury: study

A U.S.-Canadian research collaboration led by Vanderbilt University Medical Center has identified common, age-associated changes in the blood as a risk factor for acute kidney injury, which occurs in more than 1 in 5 hospitalized adults worldwide.
By Bill Snyder
March 6, 2024

New toolkit helps non-obstetricians better identify and treat pregnant and postpartum patients with cardiovascular emergencies

Vanderbilt's Kathryn Lindley, MD, has worked with the American College of Obstetricians and Gynecologists and the Centers for Disease Control and Prevention to develop a national toolkit for non-obstetricians to better identify and treat pregnant and postpartum patients with cardiovascular emergencies.
By Matt Batcheldor
March 4, 2024

Vanderbilt’s Yash Choksi and Fabian Bock honored by the Southern Society for Clinical Investigation

Vanderbilt's Yash Choksi, MD, recently received the 2024 Research Investigator Early Career Faculty Award from the Southern Society for Clinical Investigation and Fabian Bock, MD, PhD, won the society's Research Scholar Award.
By Bill Snyder
March 1, 2024

Sunil Kripalani named VP for Health System Sciences

By Bill Snyder
February 22, 2024

NIH-funded trial to determine if immunomodulation can improve brain and cardiovascular dysfunction in Long COVID

Vanderbilt University Medical Center is working with scientists around the U.S. to launch the first Phase III, multicenter, placebo-controlled trial to determine the effect of immunomodulation on Long COVID.
By Nancy Humphrey
1 … 9 10 11 12 13 … 117